Thank you, Mr. Chair.
I just want to suggest one more witness for the eighth meeting, and that's a company called AbCellera. It just had a COVID-19 therapy that was approved by PHAC and there's been an order of 26,000 of their therapies. I think that would be a really interesting addition to have in that eighth meeting.